JFJoanna Firko

Joanna Firko

*This is an algorithmically generated author record based on publicly available information.

Joanna Firko has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safety of Long-Term Creatine Supplementation in Relation to Kidney, Liver, and Skeletal Muscle Function and Reported Adverse Effects: A Narrative Review

    by Agata Sobczak, Maja Kowalczyk, Joanna Firko, Magdalena Wolff, Anna Waldman, Kalina Kreft, Lena Głuszkiewicz

    Background: Despite robust evidence supporting the ergogenic and therapeutic benefits of creatine, safety concerns regarding long-term supplementation—particularly regarding kidney, liver, and muscle health—persist. Aim: This narrative review evaluates the safety of long-term creatine supplementation on renal, hepatic, and skeletal muscle function, as well as reported adverse events. Materials and Methods: A narrative analysis of 22 scientific publications (randomized controlled trials, systematic reviews, observational studies, and experimental models) was conducted across healthy, athletic, aging, female, and clinical populations. Results: At recommended dosages, long-term creatine supplementation causes no clinically significant renal or hepatic impairment. Observed increases in serum creatinine reflect physiological turnover rather than renal dysfunction. Creatine is well-tolerated by skeletal muscle and supports muscle mass maintenance, particularly in older adults. Reported adverse effects are mild and transient, primarily involving gastrointestinal discomfort or short-term body mass changes. Conclusions: Current evidence confirms the safety of long-term creatine supplementation when used appropriately. Further research is warranted in populations with pre-existing renal or hepatic conditions.